You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

GSK2330672

Showing 1 - 10 of 10
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Cholestasis Trial in Worldwide (Placebo, GSK2330672)

Completed
Has Results
  • Cholestasis
  • Placebo
  • GSK2330672
  • Phoenix, Arizona
  • +65 more
Apr 8, 2021

Cholestasis Trial in Cambridge (GSK2330672 (linerixibat), Obeticholic acid)

Completed
Has Results
  • Cholestasis
  • GSK2330672 (linerixibat)
  • Obeticholic acid
  • Cambridge, United Kingdom
    GSK Investigational Site
Jul 1, 2020

Pruritus Trial (Linerixibat)

Completed
  • Pruritus
  • Orlando, Florida
  • +1 more
Jan 13, 2023

Diabetes, Type 2 Trial in United States (GSK2330672, Placebo, Sitagliptin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • GSK2330672
  • +3 more
  • Chula Vista, California
  • +3 more
Oct 3, 2017

Diabetes, Type 2 Trial in Miami (GSK2330672, Placebo, Metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • GSK2330672
  • +2 more
  • Miami, Florida
    GSK Investigational Site
Jul 14, 2017

Diabetes, Type 2 Trial in Minneapolis (, 0.1 mg GSK2330672, 0.3 mg GSK2330672)

Completed
  • Diabetes Mellitus, Type 2
  • placebo
  • +7 more
  • Minneapolis, Minnesota
    GSK Investigational Site
Jun 19, 2017

Cholestasis, Intrahepatic Trial in Birmingham, Cambridge, Newcastle upon Tyne (GSK2330672, Placebo, Ursodeoxycholic acid)

Completed
  • Cholestasis, Intrahepatic
  • GSK2330672
  • +2 more
  • Birmingham, West Midlands, United Kingdom
  • +2 more
Jul 31, 2017

Diabetes, Type 2 Trial in Baltimore (GSK2330672, Placebo, GSK1614235)

Completed
  • Diabetes Mellitus, Type 2
  • GSK2330672
  • +2 more
  • Baltimore, Maryland
    GSK Investigational Site
Jul 24, 2017

Cholestasis Trial in London (Linerixibat tablet, [14C]-linerixibat intravenous infusion, Linerixibat oral solution)

Completed
Has Results
  • Cholestasis
  • Linerixibat tablet
  • +2 more
  • London, United Kingdom
    GSK Investigational Site
May 29, 2020

Cholestasis Trial in Tokyo (GSK2230672, Placebo)

Completed
  • Cholestasis
  • Tokyo, Japan
    GSK Investigational Site
Nov 8, 2016